Nuo Therapeutics, Inc.
AURX
$1.23
$0.043.36%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 5.20M | 4.13M | 3.31M | 2.61M | 1.95M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.20M | 4.13M | 3.31M | 2.61M | 1.95M |
| Cost of Revenue | 1.87M | 1.43M | 1.10M | 773.50K | 467.30K |
| Gross Profit | 3.33M | 2.70M | 2.22M | 1.84M | 1.48M |
| SG&A Expenses | 5.07M | 4.92M | 4.73M | 4.40M | 4.09M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.93M | 6.35M | 5.83M | 5.18M | 4.55M |
| Operating Income | -1.73M | -2.22M | -2.52M | -2.57M | -2.60M |
| Income Before Tax | -2.01M | -2.38M | -2.51M | -2.43M | -2.47M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.01 | -2.38 | -2.51 | -2.43 | -2.47 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.01M | -2.38M | -2.51M | -2.43M | -2.47M |
| EBIT | -1.73M | -2.22M | -2.52M | -2.57M | -2.60M |
| EBITDA | -1.64M | -2.13M | -2.43M | -2.49M | -2.55M |
| EPS Basic | -0.04 | -0.05 | -0.05 | -0.05 | -0.05 |
| Normalized Basic EPS | -0.03 | -0.03 | -0.03 | -0.03 | -0.04 |
| EPS Diluted | -0.04 | -0.05 | -0.05 | -0.05 | -0.05 |
| Normalized Diluted EPS | -0.03 | -0.03 | -0.03 | -0.03 | -0.04 |
| Average Basic Shares Outstanding | 192.30M | 190.71M | 189.24M | 188.35M | 186.43M |
| Average Diluted Shares Outstanding | 192.30M | 190.71M | 189.24M | 188.35M | 186.43M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |